Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126121663 | 12612166 | 3 | F | 201607 | 20160909 | 20160801 | 20160922 | EXP | US-EMD SERONO-8097855 | EMD SERONO INC | 46.07 | YR | M | Y | 0.00000 | 20160922 | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126121663 | 12612166 | 1 | PS | REBIF | INTERFERON BETA-1A | 1 | Subcutaneous | AU016341 | 103780 | 44 | UG | INJECTION | TIW |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126121663 | 12612166 | 1 | Multiple sclerosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126121663 | 12612166 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126121663 | 12612166 | Asthenia | |
| 126121663 | 12612166 | Hyperhidrosis | |
| 126121663 | 12612166 | Hypertension | |
| 126121663 | 12612166 | Influenza like illness | |
| 126121663 | 12612166 | Injection site erythema | |
| 126121663 | 12612166 | Kidney infection | |
| 126121663 | 12612166 | Presyncope | |
| 126121663 | 12612166 | Renal impairment | |
| 126121663 | 12612166 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126121663 | 12612166 | 1 | 20160411 | 0 |